Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 169

1.

Advances in vaccine adjuvants.

Singh M, O'Hagan D.

Nat Biotechnol. 1999 Nov;17(11):1075-81. Review.

PMID:
10545912
[PubMed - indexed for MEDLINE]
2.

Recent developments in adjuvants for vaccines against infectious diseases.

O'Hagan DT, MacKichan ML, Singh M.

Biomol Eng. 2001 Oct 15;18(3):69-85. Review.

PMID:
11566599
[PubMed - indexed for MEDLINE]
3.

Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results.

Cluff CW.

Adv Exp Med Biol. 2009;667:111-23. Review.

PMID:
20429221
[PubMed - indexed for MEDLINE]
4.

Recent developments in vaccine delivery systems.

O'Hagan DT.

Curr Drug Targets Infect Disord. 2001 Nov;1(3):273-86. Review.

PMID:
12455401
[PubMed - indexed for MEDLINE]
5.

Microparticles as vaccine adjuvants and delivery systems.

O'Hagan DT, Singh M.

Expert Rev Vaccines. 2003 Apr;2(2):269-83. Review.

PMID:
12899577
[PubMed - indexed for MEDLINE]
6.

[Adjuvants--essential components of new generation vaccines].

Dzierzbicka K, Kołodziejczyk AM.

Postepy Biochem. 2006;52(2):204-11. Review. Polish.

PMID:
17078510
[PubMed - indexed for MEDLINE]
7.

Advances in vaccine adjuvants for infectious diseases.

Singh M, Srivastava I.

Curr HIV Res. 2003 Jul;1(3):309-20. Review.

PMID:
15046255
[PubMed - indexed for MEDLINE]
8.

Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results.

Cluff CW.

Adv Exp Med Biol. 2010;667:111-23. doi: 10.1007/978-1-4419-1603-7_10.

PMID:
20665204
[PubMed - indexed for MEDLINE]
9.

Bacterial ghosts as adjuvant particles.

Riedmann EM, Kyd JM, Cripps AW, Lubitz W.

Expert Rev Vaccines. 2007 Apr;6(2):241-53. Review.

PMID:
17408373
[PubMed - indexed for MEDLINE]
10.

Immune modulators with defined molecular targets: cornerstone to optimize rational vaccine design.

Ebensen T, Guzmán CA.

Hum Vaccin. 2008 Jan-Feb;4(1):13-22. Epub 2008 Jan 10. Review.

PMID:
18376145
[PubMed - indexed for MEDLINE]
Free Article
11.

From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM.

Lycke N.

Cell Microbiol. 2004 Jan;6(1):23-32. Review.

PMID:
14678328
[PubMed - indexed for MEDLINE]
12.

Novel strategies using DNA for the induction of mucosal immunity.

McCluskie MJ, Davis HL.

Crit Rev Immunol. 1999;19(4):303-29. Review.

PMID:
10530431
[PubMed - indexed for MEDLINE]
13.

Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.

Vandepapelière P, Horsmans Y, Moris P, Van Mechelen M, Janssens M, Koutsoukos M, Van Belle P, Clement F, Hanon E, Wettendorff M, Garçon N, Leroux-Roels G.

Vaccine. 2008 Mar 4;26(10):1375-86. doi: 10.1016/j.vaccine.2007.12.038. Epub 2008 Jan 14.

PMID:
18272264
[PubMed - indexed for MEDLINE]
14.

Recent advances in vaccine adjuvants.

Singh M, O'Hagan DT.

Pharm Res. 2002 Jun;19(6):715-28. Review.

PMID:
12134940
[PubMed - indexed for MEDLINE]
15.

Adjuvants in perspective.

Vogel FR.

Dev Biol Stand. 1998;92:241-8. Review.

PMID:
9554280
[PubMed - indexed for MEDLINE]
16.

Recent advances in veterinary vaccine adjuvants.

Singh M, O'Hagan DT.

Int J Parasitol. 2003 May;33(5-6):469-78. Review.

PMID:
12782048
[PubMed - indexed for MEDLINE]
17.

Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators.

Nordly P, Madsen HB, Nielsen HM, Foged C.

Expert Opin Drug Deliv. 2009 Jul;6(7):657-72. doi: 10.1517/17425240903018863. Review.

PMID:
19538037
[PubMed - indexed for MEDLINE]
18.

Recent advances in immunological adjuvants: the development of particulate antigen delivery systems.

O'Hagan DT.

Expert Opin Investig Drugs. 1998 Mar;7(3):349-59.

PMID:
15991977
[PubMed]
19.

Adjuvants for human vaccines--current status, problems and future prospects.

Gupta RK, Siber GR.

Vaccine. 1995 Oct;13(14):1263-76. Review.

PMID:
8585280
[PubMed - indexed for MEDLINE]
20.

Adjuvant formulations and delivery systems for DNA vaccines.

Sasaki S, Takeshita F, Xin KQ, Ishii N, Okuda K.

Methods. 2003 Nov;31(3):243-54. Review.

PMID:
14511957
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk